Combination of transarterial therapy with sorafenib for hepatocellular carcinoma

Authors :: Thomas J. George
Consuelo Soldevila-Pico
Giuseppe Morelli
Roberto J. Firpi
Virginia Clark
David R. Nelson
D. S. Pannu
James G. Caridi
Roniel Cabrera
Source :: Journal of Clinical Oncology. 29:e14598-e14598
Publication Year :: 2011
Publisher :: American Society of Clinical Oncology (ASCO), 2011.
Abstract: e14598 Background: Treatment with sorafenib (S) is reserved for advanced, unresectable hepatocellular carcinoma (HCC) but may provide greater efficacy when combined with transarterial therpay (T) i...

Subjects :: Oncology
Sorafenib
Cancer Research
medicine.medical_specialty
business.industry
medicine.disease
digestive system diseases
Surgery
Hepatocellular carcinoma
Internal medicine
Medicine
business
neoplasms
medicine.drug

Full Text Access

Tools